Bruce Keyt - Mar 12, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
Mar 12, 2022
Transactions value $
$0
Form type
4
Date filed
3/15/2022, 08:52 PM
Previous filing
Nov 17, 2021
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +12.5K +94.73% $0.00 25.7K Mar 12, 2022 Direct F1
holding IGMS Common Stock 1.01K Mar 12, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Award $0 +75K $0.00 75K Mar 12, 2022 Common Stock 75K $17.11 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2023 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.
F2 The shares are held directly by the Reporting Person's spouse.
F3 1/48 of the shares subject to the option shall vest on April 12, 2022 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.